Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2

Conditions

Lung Neoplasms 4Thromboembolism 2Carcinoma, Non-Small-Cell Lung 2Venous Thrombosis 1Venous Thromboembolism 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Pulmonary Embolism 1Prostatic Neoplasms 1Hemorrhage 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Dalteparin 2palbociclib 1Watchful Waiting 1Tinzaparin 1Sodium Bicarbonate 1Saline Solution 1Rivaroxaban 1High-Energy Shock Waves 1Fluoridation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Thromboembolism × Dalteparin × Thoracic × Clear all
NCT01741506 2015-06-23

COPPVATS

Aarhus University Hospital

Phase 4 Completed
116 enrolled
Thoracic

Hemorrhage, Lung Neoplasms, Thromboembolism

NCT00519805 2011-08-08

Dalteparin in Preventing Blood Clots in Patients With Lung Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
2,200 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡